-
261
Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
Published 2020-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
262
372 TAC-T cells persist and remain functional during and after repeated tumor exposure in vitro and in vivo
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
263
1229 Pre-treatment plasma proteomics-based predictive biomarkers for immune related adverse events in non-small cell lung cancer
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
264
451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
265
156 Spatial transcriptomic signatures of the fundamentals of immuno-oncology
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
266
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
267
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
Published 2020-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
268
223 CAR-T cells expressing both IL-7 and CCL19 induce epitope spreading via cross presentation of endogenous tumor antigens
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
269
Lung metastases share common immune features regardless of primary tumor origin
Published 2020-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
270
1141 Immunization with plasmid DNA versus messenger RNA encapsulated in lipid nanoparticles leads to differences in immunological outcomes
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
271
ZEB1 transcription factor promotes immune escape in melanoma
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
272
Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
Published 2022-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
273
Hypothesis: AdAPT-001 and pseudoprogression – when seeing is not necessarily believing
Published 2024-06-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
274
Correction: Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
275
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
Published 2019-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
276
1107 Enhancing immune responses to melanoma with the RIG-I antiviral pathway agonist SLR14
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
277
513 Comprehensive genomic and immune profiling of ALK fusion-positive and negative lung adenocarcinomas
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
278
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
Published 2018-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
279
1083 Functional impact of adrenergic signaling on T and NK cells: where exercise meets cancer
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
280
369 Concurrent neoantigen vaccination enhances the antitumor effect of dysfunctional T cells during cell therapy
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article